Mirae Asset Global Investments Co., Ltd. Design Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$2.27 - $4.03 $32,081 - $56,955	14,133 New	14,133 $56,000
Q2 2023 Aug 10, 2023	SELL	$4.99 - $7.64 $568 - $870	-114 Reduced 0.73%	15,398 $97,000
Q1 2023 May 04, 2023	SELL	$5.5 - $9.77 $198 - $351	-36 Reduced 0.23%	15,512 $89,000
Q4 2022 Feb 09, 2023	BUY	$7.86 - $17.2 $172 - $378	22 Added 0.14%	15,548 $159,000
Q3 2022 Nov 10, 2022	BUY	$14.09 - $25.57 $218,761 - $396,999	15,526 New	15,526 $259,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.